AVRICORE HEALTH INC.

Avricore Health (TSX-V:AVCR, OTC:AVCRF) passed a significant milestone in its commercial journey as it reported its first-ever profit in the three months ended March 31, posting $168,537 of comprehensive income. Revenue for the period increased by 79% year over year to $1.12 million, while gross profit rose by 130% to $484,791. » Mehr auf proactiveinvestors.com

Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it grew the number of pharmacy locations offering HealthTab during the third quarter of 2023, which led to an increase in revenue. In the three months ending September 30, 2023, revenue increased by 27% YoY to $953,454, with a gross profit rise of 21% to $261,778. » Mehr auf proactiveinvestors.com

Avricore Health (TSX-V:AVCR, OTC:AVCRF) said it in the first half of 2023 it continues to surpass financial targets, strike partnerships, and develop new markets as it brings its turkey solution for point-of-care testing HealthTab to additional pharmacies across Canada and internationally. The company noted that its first-half earnings were up 437% at $1,177,290 compared to the same period last year with more HealthTab systems deployed and tets sold. » Mehr auf proactiveinvestors.com